Drugs in ATC Class G01AD

Up to Top Level ATC Classes

Up to G - Genito-urinary system and sex hormones

Up to G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS

Up to G01A - ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS

Drugs in ATC Class: G01AD - Organic acids

Tradename	Generic Name
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER	calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride

G01AD Market Analysis and Financial Projection

The ATC class G01AD (Organic acids) encompasses compounds like lactic acid, acetic acid, and ascorbic acid used as gynecological anti-infectives and antiseptics. Here's an analysis of its market dynamics and patent landscape:

---

Market Dynamics

1. Growth Projections

• The global organic acids market (including G01AD applications) shows strong growth, with estimates ranging from USD 12.5 billion (2024) to USD 53 billion (2033), driven by varying methodologies and product scopes[1][4][6][12].
• For G01AD-specific pharmaceuticals, growth is fueled by:
  • Demand for pH-balancing therapies: Organic acids like lactic acid are critical in treating vaginal infections by maintaining acidic environments[13][15].
  • Rise in functional foods: Ascorbic and acetic acids are used in preservatives for functional foods, projected to exceed USD 20 billion by 2034[6].

2. Key Drivers

• Pharmaceutical innovations: Vaginal films with lactic acid (e.g., WO2021059140A1) and acetic acid gels for medical abortions demonstrate therapeutic advancements[15][16].
• Sustainable production: Shift from petrochemical-based synthesis to microbial fermentation reduces environmental impact[6][8].
• Regulatory shifts: Strict policies against synthetic preservatives boost demand for organic acid alternatives in food and medicine[4][6].

3. Regional Trends

• Asia-Pacific: Leads in production volume due to cost-effective fermentation technologies and expanding healthcare infrastructure[3][6].
• North America/Europe: Focus on high-value applications in pharmaceuticals, with acetic acid used in 3% gels for cervical treatments[16].

---

Patent Landscape

1. Innovation Trends

• Production methods: Patents like US7833763B2 highlight microbial fermentation techniques using Anaerobiospirillum bacteria to improve yield and sustainability[8].
• Formulation breakthroughs: Vaginal films incorporating lactic acid and prebiotics (e.g., WO2021059140A1) dominate recent filings, targeting urogenital health[15].

2. Geographical Distribution

• United States: Holds 230 active patents in medical device integrations (e.g., smart delivery systems for organic acids)[2].
• China: Accounts for 55% of global organic synthesis patents (2011–2020), emphasizing scalable production methods[3].
• Europe: Focus on combination therapies, such as acetic acid with misoprostol for abortion treatments[16].

3. Technology Centers

• Tech Center 2100 (U.S.): Highest allowance rate (79%) for AI-driven formulations, including predictive models for organic acid stability[5].
• WIPO: Manages 7,959 international patent families in non-pesticide applications, reflecting cross-sector use of organic acids in agriculture and medicine[10].

---

Key Contrasts in Market Data	Attribute	IMARC [1]	Maximize [4]	Fact.MR [12]
2024 Market Size	USD 28.6B	USD 12B	USD 12.3B
CAGR (2024–2033)	6.72%	5.1%	6.1%

Discrepancies stem from differing scopes (e.g., IMARC includes non-pharmaceutical uses like agriculture).

---

Future Outlook

• Biotech advancements: CRISPR-modified microbes could reduce lactic acid production costs by 30% by 2030[6][8].
• Regulatory hurdles: Section 101 rejections in the U.S. may slow AI-integrated formulation patents, pushing R&D to Asia-Pacific[5][10].

The intersection of sustainable production, therapeutic demand, and regional IP strategies will shape the G01AD organic acids sector through 2035.

References

1. https://www.imarcgroup.com/organic-acids-market
2. https://www.globenewswire.com/news-release/2025/02/25/3032292/28124/en/Orthopaedic-Braces-and-Supports-Patent-Landscape-Report-2025-United-States-Leads-with-Over-550-Patents-Filed-Historically-and-230-Currently-In-Progress.html
3. https://web.cas.org/marketing/pdf/CASGENENGBRO100993221230-NSFC-Insight-Report-A4.pdf
4. https://www.maximizemarketresearch.com/market-report/organic-acid-market/679/
5. https://www.patentnext.com/2024/12/generative-artificial-intelligence-ai-patent-application-filings-see-early-growth-trend-at-the-uspto/
6. https://www.futuremarketinsights.com/reports/global-organic-acids-market
7. https://www.youtube.com/watch?v=nvDO7biLVOo
8. https://patents.google.com/patent/US7833763B2/en
9. https://en.wikipedia.org/wiki/ATC_code_G01
10. https://www.wipo.int/web-publications/patent-landscape-report-agrifood/en/4-non-pesticide-pest-and-disease-management.html
11. https://atcddd.fhi.no/filearchive/publications/2025_guidelines__final_web.pdf
12. https://www.factmr.com/report/4285/organic-acids-market
13. https://atcddd.fhi.no/atc_ddd_index/?code=G01AD01
14. https://prediction.charite.de/subpages/tree.php
15. https://patents.google.com/patent/WO2021059140A1/en
16. https://www.pharmacompass.com/chemistry-chemical-name/domeboro